Panbela Therapeutics Inc (PBLA)
0.41
-0.02
(-4.65%)
USD |
OTCM |
May 01, 16:00
Panbela Therapeutics Cash from Operations (TTM): -25.25M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -25.25M |
September 30, 2023 | -27.17M |
June 30, 2023 | -22.09M |
March 31, 2023 | -20.54M |
December 31, 2022 | -15.28M |
September 30, 2022 | -12.50M |
June 30, 2022 | -12.27M |
March 31, 2022 | -9.763M |
December 31, 2021 | -7.245M |
September 30, 2021 | -6.13M |
June 30, 2021 | -5.536M |
March 31, 2021 | -4.699M |
December 31, 2020 | -3.854M |
September 30, 2020 | -3.613M |
June 30, 2020 | -3.301M |
March 31, 2020 | -3.076M |
December 31, 2019 | -2.739M |
September 30, 2019 | -2.029M |
June 30, 2019 | -2.216M |
March 31, 2019 | -2.582M |
December 31, 2018 | -2.387M |
September 30, 2018 | -3.008M |
June 30, 2018 | -2.629M |
Date | Value |
---|---|
March 31, 2018 | -2.918M |
December 31, 2017 | -3.402M |
September 30, 2017 | -3.447M |
June 30, 2017 | -4.125M |
March 31, 2017 | -2.928M |
December 31, 2016 | -2.398M |
September 30, 2016 | -2.448M |
June 30, 2016 | -2.387M |
March 31, 2016 | -3.532M |
December 31, 2015 | -3.897M |
September 30, 2015 | -4.188M |
June 30, 2015 | -5.517M |
March 31, 2015 | -4.266M |
December 31, 2014 | -3.343M |
September 30, 2014 | -2.072M |
June 30, 2014 | 0.1321M |
March 31, 2014 | 0.0685M |
December 31, 2013 | -0.0354M |
September 30, 2013 | -0.1716M |
June 30, 2013 | -0.1775M |
March 31, 2013 | -0.0226M |
December 31, 2012 | 0.0371M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-27.17M
Minimum
Sep 2023
-2.029M
Maximum
Sep 2019
-9.963M
Average
-6.13M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Processa Pharmaceuticals Inc | -8.063M |
Fate Therapeutics Inc | -132.26M |
Ardelyx Inc | -89.72M |
Checkpoint Therapeutics Inc | -47.59M |
Palisade Bio Inc | -11.13M |